(Q34325365)

1 August 2017

1 reference

title

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

Bezard E

1

1 reference

1 August 2017

Brotchie JM

series ordinal

2

1 reference

1 August 2017

Gross CE

series ordinal

3

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 August 2001

1 reference

Nature Reviews Neuroscience

1 August 2017

published in

1 reference

1 August 2017

volume

2

1 reference

1 August 2017

issue

8

1 reference

1 August 2017

page(s)

577-588

1 reference

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2F35086062

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Drug treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Functional architecture of basal ganglia circuits: neural substrates of parallel processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Primate models of movement disorders of basal ganglia origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Supplementary and primary sensory motor area activity in Parkinson's disease. Regional cerebral blood flow changes during finger movements and effects of apomorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Modification of Parkinsonism--chronic treatment with L-dopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Early-morning dystonia. A late side effect of long-term levodopa therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Levodopa-induced myoclonus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Continuous and intermittent levodopa differentially affect rotation induced by D-1 and D-2 dopamine agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Effects of apomorphine on globus pallidus neurons in parkinsonian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Effects of increasing doses of apomorphine during stereotaxic neurosurgery in Parkinson's disease: clinical score and internal globus pallidus activity. Short communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Cortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

L-Dopa-Induced Release of Cerebral Monoamines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Mechanisms of the effects of exogenous levodopa on the dopamine-denervated striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Continuous dopamine-receptor stimulation in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Continuous dopamine-receptor stimulation in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Continuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Plasma O-methyldopa in levodopa-induced dyskinesias. A bioclinical investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

L-DOPA modulates striatal dopaminergic function in vivo: evidence from PET investigations in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

A dopamine- and cyclic AMP-regulated phosphoprotein enriched in dopamine-innervated brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Molecular effects of dopamine on striatal-projection pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Dynorphin regulates D1 dopamine receptor-mediated responses in the striatum: relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate-early gene induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

From experimentation to the surgical treatment of Parkinson's disease: prelude or suite in basal ganglia research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Synaptic transmission in the striatum: from plasticity to neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Unilateral dopamine depletion increases expression of the 2A subunit of the N-methyl-D-aspartate receptor in enkephalin-positive and enkephalin-negative neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Neostriatal enkephalin-immunoreactive neurones project to the globus pallidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

On the role of enkephalin cotransmission in the GABAergic striatal efferents to the globus pallidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Effects of opioid agonist drugs on the in vitro release of 3H-GABA, 3H-dopamine and 3H-5HT from slices of rat globus pallidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Potential of opioid antagonists in the treatment of levodopa-induced dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurrence of dyskinesia in normal monkeys chronically treated with L-DOPA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Modulation of glutamate release by a kappa-opioid receptor agonist in rodent and primate striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

High dose naltrexone for dyskinesias induced by levodopa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Effect of an Opiate Antagonist on Movement Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Naltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Cellular distribution of adenosine A2A receptor mRNA in the primate striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Pathophysiology and biochemistry of dyskinesia: clues for the development of non-dopaminergic treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

Effects of an alpha2 antagonist ina 20-year-old Java monkey with MPTP-induced parkinsonian signs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

The alpha2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

"On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

"On-off" effects in patients with Parkinson's disease on chronic levodopa therapy

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Parkinson Study Group

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Speculations on the functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Pallidotomy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Serotonergic neurones are not involved in action of L-dopa in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-dopa in parkinsonism

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Control of on/off phenomenon by continuous intravenous infusion of levodopa

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Repeated Levodopa Infusions in Fluctuating Parkinsonʼs Disease

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Receptor basis for dopaminergic supersensitivity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Internalization of D1 dopamine receptor in striatal neurons in vivo as evidence of activation by dopamine agonists.

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

A complex program of striatal gene expression induced by dopaminergic stimulation.

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons.

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-dopa in the MPTP-treated marmoset

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Effects of L-DOPA on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Endomorphin-1: induction of motor behavior and lack of receptor desensitization.

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Opposite roles of D1 and D5 dopamine receptors in locomotion revealed by selective antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Effect of naloxone on the "on-off' syndrome in patients receiving long-term levodopa therapy

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Effect of the alpha 2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.

1 reference

https://api.crossref.org/works/10.1038%2F35086062

7 January 2021

Identifiers

DOI

10.1038/35086062

1 reference

Dimensions Publication ID

1 August 2017

1013971521

0 references

1 reference